Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
FDA Approves Benralizumab for EGPA Vasculitis Indication
The US Food and Drug Administration (FDA) has approved benralizumab (Fasenra) for the treatment of adults with eosinophilic granulomatosis with polyangiitis (EGPA), formerly known as Churg-Strauss syndrome. The drug is the second approved biologic for the treatment of EGPA. The…
English